NATHBIOGEN2023-04-012023-06-30 NATHBIOGEN2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member NATHBIOGEN2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member NATHBIOGEN2023-06-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 537291 NATHBIOGEN NA Nath Bio-Genes (India) Limited Equity 2023-04-01 2024-03-31 2023-08-10 2023-08-02 INR Lakhs First quarter 15:30:00 17:25:00 2023-08-10 2023-08-10 Not applicable Single segment SEED CULTIVATION 2023-04-01 2023-06-30 Unaudited Consolidated 2352816000.00 1170000.00 2353986000.00 694248000.00 20705000.00 512864000.00 71870000.00 27645000.00 7600000.00 685047000.00 2019979000.00 334007000.00 0.00 334007000.00 2201000.00 0.00 2201000.00 0.00 331806000.00 0.00 0.00 0.00 0.00 331806000.00 0.00 331806000.00 0.00 0.00 0.00 0.00 190040000.00 10 17.47 17.47 0.00 0.00 17.47 17.47 (1) The consolodated financial results were reviewed by the Audit Committee in meeting held on 09 August 2023 and were thereafter approved by the Board of Directors at its meeting held on 10 August 2023. (2) The company is dealing in one major product segment, le Seed Cultivation (3) The results have been consolidated with Nath Bio-Genes CA. Uzbekistan, where in the compnay is holding 90% of equity. (4) Investor complaints - Opening Balance -0. Received and Solved - 1, Closing Balance - 0 (5) The figures have been regrouped/rearranged where ever necessary. Other Expenses 56500000.00 Selling and Distribution Expenses 628547000.00 0.00 0.00